Richard Batrla

CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts

Oskar Hansson, John Seibyl, Erik Stomrud et al. · Alzheimer s & Dementia · 2018 · 829 citations · Full text

Medicine, Neurology, Neuroscience +17

Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B # †

Maurizia Rossana Brunetto, F. Moriconi, Ferruccio Bonino et al. · Hepatology · 2008 · 483 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum

Carol Van Hulle, Erin M. Jonaitis, Tobey J. Betthauser et al. · Alzheimer s & Dementia · 2020 · 155 citations · Full text

Medicine, Neurology, Neuroscience +17

The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau

Oskar Hansson, Richard Batrla, Britta Brix et al. · Alzheimer s & Dementia · 2021 · 126 citations · Full text

Medicine, Clinical Sciences, Neurology +17

Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients

Michelle Martinot-Peignoux, Roberto José de Carvalho‐Filho, Martine Lapalus et al. · Journal of Hepatology · 2013 · 114 citations

Medicine, Immunology, Pathology +12